News, Analysis & Insights on Nutrition, Supplements, and Health
Pep2Dia® is a patented milk protein hydrolysate with an active dipeptide AP which acts as an inhibitor of the alpha glucosidase. This digestive enzyme hydrolyses polysaccharides into glucose and allows absorption. Its inhibition lowers blood sugar levels. Pep2Dia® has proven efficacy on glycaemia after meals. Pre-clinical and clinical studies support Pep2Dia®’s action to reduce postprandial glycaemia with a significative effect versus the placebo.
Paid for and content provided by INGREDIA DAIRY EXPERTS
Sleeping disorders affect nearly 30% of the adult population and 20% to 30% of children from all ages (0-18 years). Insomnia is defined with one or more of the following symptoms: difficulty falling asleep, difficulty staying asleep with several night...
Paid for and content provided by INGREDIA DAIRY EXPERTS
Athletes who practice resistance-type exercises have particular protein needs: these can be as high as two to three times the recommendation. But endurance athletes (i.e. a moderate intensity sport over a relatively long period such as running, cycling...
Join Ingredia experts to discover the science and very first consumer results on our brand-new joint health ingredient Xelflex®!
Join us as we unveil the first in‑vitro results on our product’s digestibility profile.
For more product information visit INGREDIA DAIRY EXPERTS.